Ligand Pharmaceuticals Incorporated (LGND) SEC filings
LGND SEC filings moved a median of +0.34% by the close. LGND SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the LGND overview →
75 measured LGND SEC filing events.
Where these LGND SEC filings landedvs 74 measured LGND SEC filing reactions
| Middle 50% of LGND SEC filing reactions | -1.88% to +2.53% |
|---|---|
| Median reaction (to close) | +0.34% |
| Measured reactions | 74 |
Point-in-time · zero look-ahead
Half of the 74 LGND SEC filing events with a measured close landed between -1.88% and +2.53%; 57% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K LIGAND PHARMACEUTICALS For: Sep 24 | SEC filing · Form 8-K | +0.42% | +0.70% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Sep 22 | SEC filing · Form 8-K | -0.52% | +2.58% | |
| Form 8-K/A LIGAND PHARMACEUTICALS For: Jul 14 | SEC filing · Form 8-K | +1.10% | +0.98% | |
| Form 10-Q LIGAND PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +0.97% | — | |
| Form 8-K LIGAND PHARMACEUTICALS For: Aug 06 | SEC filing · Form 8-K | +1.29% | -1.94% | |
| Form S-8 LIGAND PHARMACEUTICALS | SEC filing · Form S-8 | +0.59% | +0.56% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Jul 14 | SEC filing · Form 8-K | -0.31% | -2.68% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Jun 25 | SEC filing · Form 8-K | -2.91% | +3.07% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Jun 22 | SEC filing · Form 8-K | -3.47% | -2.08% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Jun 05 | SEC filing · Form 8-K | +3.54% | +1.32% | |
| Form 8-K LIGAND PHARMACEUTICALS For: May 16 | SEC filing · Form 8-K | +0.00% | -2.94% | |
| Form DEFA14A LIGAND PHARMACEUTICALS | SEC filing · Form DEFA14A | +0.00% | -2.94% | |
| Form 10-Q LIGAND PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -1.54% | -0.42% | |
| Form 8-K LIGAND PHARMACEUTICALS For: May 07 | SEC filing · Form 8-K | +6.93% | +2.60% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Apr 24 | SEC filing · Form 8-K | -0.57% | -1.06% | |
| Form DEFA14A LIGAND PHARMACEUTICALS | SEC filing · Form DEFA14A | -0.40% | -4.65% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Apr 27 | SEC filing · Form 8-K | -3.65% | -0.86% | |
| Form DEFA14A LIGAND PHARMACEUTICALS | SEC filing · Form DEFA14A | +0.84% | +1.17% | |
| Form ARS LIGAND PHARMACEUTICALS For: Dec 31 | SEC filing · Form ARS | +0.00% | -0.51% | |
| Form DEF 14A LIGAND PHARMACEUTICALS For: Dec 31 | SEC filing · Form DEF | +0.00% | -0.51% | |
| Form DEFA14A LIGAND PHARMACEUTICALS | SEC filing · Form DEFA14A | +0.00% | -0.51% | |
| Form 10-K LIGAND PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +0.00% | +2.71% | |
| Form S-3ASR LIGAND PHARMACEUTICALS | SEC filing · Form S-3ASR | +0.00% | +2.71% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Feb 26 | SEC filing · Form 8-K | -1.97% | +2.69% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Dec 18 | SEC filing · Form 8-K | +2.34% | +1.24% | |
| Form 10-Q LIGAND PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +0.70% | +2.37% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Nov 06 | SEC filing · Form 8-K | +1.02% | +6.24% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Sep 12 | SEC filing · Form 8-K | -0.20% | -0.76% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Aug 11 | SEC filing · Form 8-K | -0.96% | -2.71% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Aug 11 | SEC filing · Form 8-K | +2.53% | +6.24% | |
| Form 10-Q LIGAND PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +2.53% | +6.24% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Aug 07 | SEC filing · Form 8-K | -0.99% | +1.05% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Jul 02 | SEC filing · Form 8-K | -1.38% | +0.34% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Jun 09 | SEC filing · Form 8-K | +0.95% | +3.59% | |
| Form 10-Q LIGAND PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -0.42% | -1.08% | |
| Form 8-K LIGAND PHARMACEUTICALS For: May 08 | SEC filing · Form 8-K | -0.86% | -4.13% | |
| Form ARS LIGAND PHARMACEUTICALS For: Dec 31 | SEC filing · Form ARS | +0.90% | -3.42% | |
| Form DEF 14A LIGAND PHARMACEUTICALS For: Dec 31 | SEC filing · Form DEF | +0.90% | -3.42% | |
| Form DEFA14A LIGAND PHARMACEUTICALS | SEC filing · Form DEFA14A | +0.90% | -3.42% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Apr 16 | SEC filing · Form 8-K | -0.60% | +0.70% | |
| Form 10-K LIGAND PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | -0.41% | -8.15% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Feb 27 | SEC filing · Form 8-K | +1.13% | +3.52% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Feb 24 | SEC filing · Form 8-K | +0.99% | -3.79% | |
| Form 10-Q LIGAND PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +0.39% | +1.01% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Nov 07 | SEC filing · Form 8-K | -1.29% | +9.78% | |
| Form 10-Q LIGAND PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +2.07% | +3.56% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Aug 06 | SEC filing · Form 8-K | -1.25% | -6.68% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Aug 02 | SEC filing · Form 8-K | +2.71% | +8.68% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Jul 15 | SEC filing · Form 8-K | +0.00% | -1.53% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Jul 08 | SEC filing · Form 8-K | +0.88% | +0.72% | |
| Form S-8 LIGAND PHARMACEUTICALS | SEC filing · Form S-8 | +0.16% | +4.67% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Jul 08 | SEC filing · Form 8-K | -0.83% | +1.15% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Jun 27 | SEC filing · Form 8-K | +1.93% | +4.95% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Jun 18 | SEC filing · Form 8-K | +0.00% | -0.11% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Jun 14 | SEC filing · Form 8-K | +0.00% | +0.34% | |
| Form DEFA14A LIGAND PHARMACEUTICALS | SEC filing · Form DEFA14A | -0.89% | -6.90% | |
| Form 8-K LIGAND PHARMACEUTICALS For: May 29 | SEC filing · Form 8-K | +0.00% | +0.61% | |
| Form DEFA14A LIGAND PHARMACEUTICALS | SEC filing · Form DEFA14A | -1.73% | +2.05% | |
| Form 10-Q LIGAND PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +2.02% | +8.64% | |
| Form 8-K LIGAND PHARMACEUTICALS For: May 06 | SEC filing · Form 8-K | +0.73% | -0.38% | |
| Form 8-K LIGAND PHARMACEUTICALS For: May 07 | SEC filing · Form 8-K | -1.60% | +8.05% | |
| Form ARS LIGAND PHARMACEUTICALS For: Dec 31 | SEC filing · Form ARS | -0.87% | +0.18% | |
| Form DEF 14A LIGAND PHARMACEUTICALS For: Dec 31 | SEC filing · Form DEF | -0.87% | +0.18% | |
| Form DEFA14A LIGAND PHARMACEUTICALS | SEC filing · Form DEFA14A | -0.87% | +0.18% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Apr 17 | SEC filing · Form 8-K | -2.00% | -6.10% | |
| Form S-8 LIGAND PHARMACEUTICALS | SEC filing · Form S-8 | -1.09% | -3.14% | |
| Form 10-K LIGAND PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.69% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Feb 27 | SEC filing · Form 8-K | -3.15% | +4.72% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Jan 05 | SEC filing · Form 8-K | -2.15% | +0.77% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Nov 29 | SEC filing · Form 8-K | +0.00% | +0.98% | |
| Form 8-K/A LIGAND PHARMACEUTICALS For: Nov 09 | SEC filing · Form 8-K | +0.00% | +0.07% | |
| Form 10-Q LIGAND PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +0.40% | +1.09% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Nov 08 | SEC filing · Form 8-K | -6.18% | -0.64% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Oct 12 | SEC filing · Form 8-K | +0.00% | -3.49% | |
| Form 8-K LIGAND PHARMACEUTICALS For: Oct 18 | SEC filing · Form 8-K | +0.00% | -3.49% |
Keep exploring
More LGND: earnings → · analyst actions → · LGND overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | 368 | -0.13% | 49% |
| Arcus Biosciences, Inc. (RCUS) | 368 | -0.09% | 45% |
| Microbot Medical Inc. (MBOT) | 366 | -0.19% | 43% |
| SOPHIRIS BIO INC (SPHS) | 366 | -0.23% | 37% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.